Gabriela G. Cezar

Dr. Cezar co-founded at Stemina Biomarker Discovery in 2006.
Previously, she served as a senior principal scientist at Pfizer, working on global projects to incorporate stem cells in drug discovery and toxicology.
In her role at Pfizer, she also developed in vivo models (genetically modified mice) for target validation in multiple therapeutic areas.
Overall, she has extensive experience on integration and application of molecular technologies to pharmaceutical discovery and development.
She is also a assistant professor at the University of Wisconsin-Madison.
Dr. Cezar is a member of the Science Advisory Board of the Genetics Policy Institute, a leading nonprofit organization dedicated to establishing a positive legal framework to advance stem cell research, as well as other stem cell-related organizations and patient advocacy groups.
She is an internationally renowned invited speaker at numerous conferences.